318 related articles for article (PubMed ID: 34830300)
21. Minimal residual disease in melanoma: circulating melanoma cells and predictive role of MCAM/MUC18/MelCAM/CD146.
Rapanotti MC; Campione E; Spallone G; Orlandi A; Bernardini S; Bianchi L
Cell Death Discov; 2017; 3():17005. PubMed ID: 28280601
[TBL] [Abstract][Full Text] [Related]
22. The membrane protein melanoma cell adhesion molecule (MCAM) is a novel tumor marker that stimulates tumorigenesis in hepatocellular carcinoma.
Wang J; Tang X; Weng W; Qiao Y; Lin J; Liu W; Liu R; Ma L; Yu W; Yu Y; Pan Q; Sun F
Oncogene; 2015 Nov; 34(47):5781-95. PubMed ID: 25728681
[TBL] [Abstract][Full Text] [Related]
23. Melanoma progression-associated glycoprotein MUC18/MCAM mediates homotypic cell adhesion through interaction with a heterophilic ligand.
Johnson JP; Bar-Eli M; Jansen B; Markhof E
Int J Cancer; 1997 Nov; 73(5):769-74. PubMed ID: 9398060
[TBL] [Abstract][Full Text] [Related]
24. Bioimmunotherapy for melanoma using fully human antibodies targeting MCAM/MUC18 and IL-8.
Melnikova VO; Bar-Eli M
Pigment Cell Res; 2006 Oct; 19(5):395-405. PubMed ID: 16965268
[TBL] [Abstract][Full Text] [Related]
25. Polymerase chain reaction-based detection of circulating melanoma cells as an effective marker of tumor progression. Melanoma Cooperative Group.
Palmieri G; Strazzullo M; Ascierto PA; Satriano SM; Daponte A; Castello G
J Clin Oncol; 1999 Jan; 17(1):304-11. PubMed ID: 10458247
[TBL] [Abstract][Full Text] [Related]
26. Immunohistochemical Expression of MCAM/CD146 in Canine Melanoma.
Abou Asa S
J Comp Pathol; 2017 Jul; 157(1):27-33. PubMed ID: 28735667
[TBL] [Abstract][Full Text] [Related]
27. Synovial fluid CD146 (MUC18), a marker for synovial membrane angiogenesis in rheumatoid arthritis.
Neidhart M; Wehrli R; Brühlmann P; Michel BA; Gay RE; Gay S
Arthritis Rheum; 1999 Apr; 42(4):622-30. PubMed ID: 10211875
[TBL] [Abstract][Full Text] [Related]
28. Isolation and characterization of the major form of human MUC18 cDNA gene and correlation of MUC18 over-expression in prostate cancer cell lines and tissues with malignant progression.
Wu GJ; Wu MW; Wang SW; Liu Z; Qu P; Peng Q; Yang H; Varma VA; Sun QC; Petros JA; Lim SD; Amin MB
Gene; 2001 Nov; 279(1):17-31. PubMed ID: 11722842
[TBL] [Abstract][Full Text] [Related]
29. β-1,3-Galactosyl-
Sumardika IW; Youyi C; Kondo E; Inoue Y; Ruma IMW; Murata H; Kinoshita R; Yamamoto KI; Tomida S; Shien K; Sato H; Yamauchi A; Futami J; Putranto EW; Hibino T; Toyooka S; Nishibori M; Sakaguchi M
Oncol Res; 2018 Apr; 26(3):431-444. PubMed ID: 28923134
[TBL] [Abstract][Full Text] [Related]
30. The role of N-cadherin, MCAM and beta3 integrin in melanoma progression, proliferation, migration and invasion.
Watson-Hurst K; Becker D
Cancer Biol Ther; 2006 Oct; 5(10):1375-82. PubMed ID: 16969099
[TBL] [Abstract][Full Text] [Related]
31. MCAM, as a novel receptor for S100A8/A9, mediates progression of malignant melanoma through prominent activation of NF-κB and ROS formation upon ligand binding.
Ruma IM; Putranto EW; Kondo E; Murata H; Watanabe M; Huang P; Kinoshita R; Futami J; Inoue Y; Yamauchi A; Sumardika IW; Youyi C; Yamamoto K; Nasu Y; Nishibori M; Hibino T; Sakaguchi M
Clin Exp Metastasis; 2016 Aug; 33(6):609-27. PubMed ID: 27151304
[TBL] [Abstract][Full Text] [Related]
32. The progression associated antigen MUC18: a unique member of the immunoglobulin supergene family.
Johnson JP; Rothbächer U; Sers C
Melanoma Res; 1993 Oct; 3(5):337-40. PubMed ID: 8292890
[TBL] [Abstract][Full Text] [Related]
33. Gene regulation in melanoma progression by the AP-2 transcription factor.
Bar-Eli M
Pigment Cell Res; 2001 Apr; 14(2):78-85. PubMed ID: 11310795
[TBL] [Abstract][Full Text] [Related]
34. Immunization against MUC18/MCAM, a novel antigen that drives melanoma invasion and metastasis.
Leslie MC; Zhao YJ; Lachman LB; Hwu P; Wu GJ; Bar-Eli M
Gene Ther; 2007 Feb; 14(4):316-23. PubMed ID: 17024104
[TBL] [Abstract][Full Text] [Related]
35. Detection of circulating melanoma cells in the blood of melanoma patients: a preliminary study.
Roland CL; Ross MI; Hall CS; Laubacher B; Upshaw J; Anderson AE; Lucci A
Melanoma Res; 2015 Aug; 25(4):335-41. PubMed ID: 26011119
[TBL] [Abstract][Full Text] [Related]
36. Improved diagnosis and prognostication of patients with pleural malignant mesothelioma using biomarkers in pleural effusions and peripheral blood samples - a short report.
Beije N; Kraan J; den Bakker MA; Maat APWM; van der Leest C; Cornelissen R; Van NM; Martens JWM; Aerts JGJV; Sleijfer S
Cell Oncol (Dordr); 2017 Oct; 40(5):511-519. PubMed ID: 28577209
[TBL] [Abstract][Full Text] [Related]
37. Phorbol ester and cyclic AMP-mediated regulation of the melanoma-associated cell adhesion molecule MUC18/MCAM.
Rummel MM; Sers C; Johnson JP
Cancer Res; 1996 May; 56(9):2218-23. PubMed ID: 8616875
[TBL] [Abstract][Full Text] [Related]
38. Dual role of melanoma cell adhesion molecule (MCAM)/CD146 in lymphocyte endothelium interaction: MCAM/CD146 promotes rolling via microvilli induction in lymphocyte and is an endothelial adhesion receptor.
Guezguez B; Vigneron P; Lamerant N; Kieda C; Jaffredo T; Dunon D
J Immunol; 2007 Nov; 179(10):6673-85. PubMed ID: 17982057
[TBL] [Abstract][Full Text] [Related]
39. Fully human antibodies to MCAM/MUC18 inhibit tumor growth and metastasis of human melanoma.
Mills L; Tellez C; Huang S; Baker C; McCarty M; Green L; Gudas JM; Feng X; Bar-Eli M
Cancer Res; 2002 Sep; 62(17):5106-14. PubMed ID: 12208768
[TBL] [Abstract][Full Text] [Related]
40. CREB inhibits AP-2alpha expression to regulate the malignant phenotype of melanoma.
Melnikova VO; Dobroff AS; Zigler M; Villares GJ; Braeuer RR; Wang H; Huang L; Bar-Eli M
PLoS One; 2010 Aug; 5(8):e12452. PubMed ID: 20805990
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
